A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis-Reference-Cited by-同舟云学术

A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis

Published:2015-05-11 Issue:6 Volume:47 Page:615-624
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Moriarity Branden S,Otto George M,Rahrmann Eric P,Rathe Susan K,Wolf Natalie K,Weg Madison T,Manlove Luke A,LaRue Rebecca S,Temiz Nuri A^ORCID,Molyneux Sam D,Choi Kwangmin,Holly Kevin J,Sarver Aaron L,Scott Milcah C,Forster Colleen L,Modiano Jaime F,Khanna Chand,Hewitt Stephen M,Khokha Rama,Yang Yi,Gorlick Richard,Dyer Michael A,Largaespada David A

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.3293.pdf

Reference85 articles.

1. Kansara, M. & Thomas, D.M. Molecular pathogenesis of osteosarcoma. DNA Cell Biol. 26, 1–18 (2007).

2. Allison, D.C. et al. A meta-analysis of osteosarcoma outcomes in the modern medical era. Sarcoma 2012, 704872 (2012).

3. Jaffe, N., Puri, A. & Gelderblom, H. Osteosarcoma: evolution of treatment paradigms. Sarcoma 2013, 203531 (2013).

4. Tsuchiya, H. et al. Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: the Japanese Musculoskeletal Oncology Group study. J. Clin. Oncol. 20, 3470–3477 (2002).

5. Kager, L. et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J. Clin. Oncol. 21, 2011–2018 (2003).

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arid1a Loss Enhances Disease Progression in a Murine Model of Osteosarcoma;Cancers;2024-07-31

2. Identification of hub genes related to metastasis and prognosis of osteosarcoma and establishment of a prognostic model with bioinformatic methods;Medicine;2024-06-07

3. POLE2 promotes osteosarcoma progression by enhancing the stability of CD44;Cell Death Discovery;2024-04-16

4. A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614);Pediatric Blood & Cancer;2024-03-23

5. Genomic analysis of an aggressive hepatic leiomyosarcoma case following treatment for hepatocellular carcinoma;Hepatology Research;2024-03-09